[Epidemiological data and medical care situation of patients with chronic inflammatory diseases in Germany : Real-world evidence on prevalence, disease combinations, care].

Autor: Riemekasten G; Klinik für Rheumatologie und klinische Immunologie, Universitätsklinikum Schleswig-Holstein, Lübeck, Deutschland., Schmelz R; Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus Dresden, Fetscherstr. 74, 01307, Dresden, Deutschland. Renate.Schmelz@uniklinikum-dresden.de., Schäkel K; Hautklinik, IZEH - Interdisziplinäres Zentrum für chronisch entzündliche Erkrankungen, Universitätsklinikum Heidelberg, Heidelberg, Deutschland., Thaci D; Institut und Exzellenzzentrum für Entzündungsmedizin, Universität zu Lübeck, Lübeck, Deutschland., Schreiber S; Klinik für Innere Medizin I und Institut für Klinische Molekularbiologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Deutschland., Röcken M; Janssen-Cilag GmbH, Neuss, Deutschland., Bartz H; Janssen-Cilag GmbH, Neuss, Deutschland., Ploner T; InGef - Institut für angewandte Gesundheitsforschung Berlin GmbH, Berlin, Deutschland., Liao X; InGef - Institut für angewandte Gesundheitsforschung Berlin GmbH, Berlin, Deutschland., Weber V; IGES Institut GmbH, Berlin, Deutschland., Manz KC; IGES Institut GmbH, Berlin, Deutschland., Burkhardt H; Medizinische Klinik II/Rheumatologie, Fraunhofer Institut für Translationale Medizin und Pharmakologie (ITMP), Universitätsklinikum Frankfurt, Goethe-Universität Frankfurt am Main, Frankfurt, Deutschland., Leipe J; Sektion Rheumatologie, V. Medizinische Klinik, Universitätsklinikum Mannheim, Mannheim, Deutschland.
Jazyk: němčina
Zdroj: Zeitschrift fur Rheumatologie [Z Rheumatol] 2024 Sep; Vol. 83 (7), pp. 578-586. Date of Electronic Publication: 2023 Dec 09.
DOI: 10.1007/s00393-023-01459-7
Abstrakt: Background: Chronic inflammatory diseases (immune-mediated inflammatory diseases, IMID) can overlap or occur simultaneously due to clinical similarities. The resulting utilization of heathcare structures has not yet been investigated across disciplines but is of potential importance for optimizing the treatment of patients with IMID.
Aim of the Work: Analysis of epidemiological data including utilization of care services in patients with selected IMIDs: psoriasis, psoriatic arthritis (PsA), rheumatoid arthritis (RA), ankylosing spondylitis, ulcerative colitis, Crohn's disease and connective tissue disease.
Material and Methods: In a retrospective cross-sectional analysis based on health insurances accounting data with a sample of approximately 4 million insured persons, the prevalence of the abovementioned IMID and the frequency of IMID combinations were analyzed based on documented diagnoses (ICD-10 GM). The frequency of hospitalizations and utilization of outpatient physician contacts was recorded in predefined specialist disciplines (general medicine, dermatology, gastroenterology, rheumatology) and compared with an age-adjusted and gender-adjusted reference population.
Results: A total of 188,440 patients had at least 1 of the IMID diagnoses analyzed (4.7%), with an age peak of 61-70 years. The highest prevalence was observed for psoriasis (1.85%), followed by rheumatoid arthritis (1.38%). Combinations with at least one other IMID were relatively common (29%), with this being most common in patients with psoriatic arthritis (82.9%, of which 68.2% had psoriasis), followed by ankylosing spondylitis (27.5%) and Crohn's disease (21.6%). Compared to the reference population, patients with IMID were hospitalized more often and more frequently utilized the outpatient disciplines.
Discussion: The study results describe that IMIDs occur in combination and that the patients make comparatively more use of care structures of different disciplines. A multidisciplinary approach could increase the efficiency of care; an evaluation is still pending.
(© 2023. The Author(s).)
Databáze: MEDLINE
Externí odkaz: